Hepatitis B

At long last, Sanofi launches low-cost pentavalent in India

It's been a long road for Shan5, the low-cost pentavalent from Sanofi-owned Shantha Biotechnics. Now, after manufacturing tie-ups four years ago cost the company a $340 million contract to supply the vaccine, it's finally rolling out the product in India.
 
With the launch, 27 million babies born annually in India will now have access to the 5-in-1 shot, which protects children against diphtheria, tetanus, pertussis, Hib and hepatitis B, according to Shantha CEO Harish Iyer.
 
Undefined

de nouvelles armes pour lutter contre les hépatites

Les hépatites virales sont des maladies du foie silencieuses qui passent souvent inaperçues. Elles peuvent dans certains cas (hépatite B ou C) devenir une maladie chronique pouvant entraîner des complications graves comme la cirrhose ou le cancer du foie. C'est ce qui en fait la gravité."
 
Undefined

FDA clears syringe that prevents needlestick injuries

Exton, PA's West Pharmaceutical Services just announced that the FDA has given it 510(k) clearance for the NovaGuard Staked-needle Automatic safety system, as the push to avoid needlestick injuries gathers momentum.
 
The company says that the device shields the syringe's exposed needle after it has been activated and contains a tamper-evident safety mechanism to prevent early activation of the device.
 
Undefined

At long last, Sanofi launches low-cost pentavalent in India

It's been a long road for Shan5, the low-cost pentavalent from Sanofi-owned Shantha Biotechnics. Now, after manufacturing tie-ups four years ago cost the company a $340 million contract to supply the vaccine, it's finally rolling out the product in India.
 
With the launch, 27 million babies born annually in India will now have access to the 5-in-1 shot, which protects children against diphtheria, tetanus, pertussis, Hib and hepatitis B, according to Shantha CEO Harish Iyer.
 
Undefined

India plans to add 5-in-1 vaccine in every state

Two Indian states will add a new pentavalent vaccine into their routine immunization schedules this week.
 
The 5-in-1 vaccine protects against hepatitis B (hepB), Haemophilus influenza type b (Hib), and diphtheria, tetanus and pertussis (DTP).
 
Continuing the Phase One rollout of the vaccine, Madhya Pradesh and Rejasthan will join eight other states currently offering the vaccine for free as part of a project by the vaccine alliance, Gavi. Ten additional states will also begin offering the pentavalent vaccine before the year is over.
Undefined

The Psychology of Anti-Vaxers: How Story Trumps Science

Skyler Smoot, a cooing, smiling 12-week-old baby, is in danger. His brown eyes sparkle, his toes wiggle, his hands wave, but his health lies at the heart of a controversy between parents and doctors.
 
“I’m just afraid, you know?” his mother, Jacklyn, says. “I’m afraid of what could happen to him.”
 
Skyler isn’t vaccinated.
 
Undefined

ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) MEETING

From the US Centers for Disease Control and Prevention (US CDC) website:
Undefined

10 questions sur les vaccins et la vaccination

Les vaccins, c’est l’enfer ! Entre le carnet de vaccination perdu ou le médecin contacté en urgence qui ignore tout de notre situation, on ne sait plus vraiment où l’on en est dans notre calendrier de vaccins… Et si on mettait le nez dedans une bonne fois pour toute au lieu de laisser les choses s’enliser ?
 
Mon dernier vaccin date du collège, je dois faire lequel ?
Undefined

Pentavalent vaccine now available in 73 countries

The GAVI Alliance announced on Wednesday that the five-in-one pentavalent vaccine is now available in 73 countries.
 
South Sudan became the latest GAVI-supported country to introduce the vaccine on July 16, according to a GAVI Alliance press release.
 
The South Sudanese government said that 450,000 children will receive the vaccine over the next year. The GAVI Alliance estimates that more than 230 million children globally will receive the vaccine by the end of 2015.
 
Undefined

Pages